Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Aspalatone is an anti-platelet aggregator (IC50 = 180 μM, in vitro) that prolongs bleeding time significantly in a rodent model of thromboembolism. Additionally at a minimal effective dose of 24 mg/kg, aspalatone generates antioxidant and neuroprotective effects against kainic acid-induced epilepsy in rat hippocampus.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
5 mg | 約 35 days | ¥ 20,500 |
10 mg | 約 35 days | ¥ 38,000 |
50 mg | 約 35 days | ¥ 157,500 |
100 mg | 約 35 days | ¥ 273,500 |
説明 | Aspalatone is an anti-platelet aggregator (IC50 = 180 μM, in vitro) that prolongs bleeding time significantly in a rodent model of thromboembolism. Additionally at a minimal effective dose of 24 mg/kg, aspalatone generates antioxidant and neuroprotective effects against kainic acid-induced epilepsy in rat hippocampus. |
分子量 | 288.25 |
分子式 | C15H12O6 |
CAS No. | 147249-33-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 1 mg/mL
DMSO: 10 mg/mL
DMF: 10 mg/mL
DMSO:PBS (pH 7.2) (1:10): 0.1 mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Aspalatone 147249-33-0 Inhibitor inhibitor inhibit